Clinical and pharmacological analysis of patients with acute coronary syndrome under 45 years of age: A prospective cohort study

Author:

Badai NashtarORCID,Nazzal MuhammedORCID,Faeq HayderORCID,Abidi AfrozORCID

Abstract

Background/Aim: Acute coronary syndrome (ACS) in young people is a problem of growing concern. There is an increasing need to evaluate this disease and predict its sequelae for better prevention and management. Aim of this study was to analyse clinical and pharmacological aspects of ACS hospitalised patients for a better evaluation and prediction. Methods: The study included questionnaire based data taken from 225 patients (207 males, 18 females) admitted to Ibn Al-Nafees tertiary cardiac centre. Socioeconomic , clinical and pharmacological data were obtained from all patients with follow up from time of admission to discharge. Results: Male to female ratio was 11.5:1, anterior infarction was the predominant site (54.6 %), mortality rate was 1.3 %. Ejection fraction (LVEF) was below 45 % in 66.7 % of the patients, majority (70.7 %) with ischaemic hypokinesia. Smoking was the most common risk factor (77.3 %). Heart failure (HF) was the most common complication (57.3 %). There were significant relationship between HF occurrence and number of risk factors , LVEF, anterior site of ACS and number of echo findings. There were non-significant increase in relative risk of HF with each risk factor, positive troponin and pre-admission pain duration. Prediction tests showed an ascending positive slope of HF risk with number of risk factors, duration of admission and age. Conclusion: There was a high rate of HF occurrence in this study which is mostly attributed to major wall damage due to blockage of the main coronary artery. Analysis demonstrated a good survival rate but high rate of HF occurrence urges for more consideration of guideline-directed management .

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Reference39 articles.

1. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-826. doi: 10.1093/eurheartj/ehad191;

2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184;

3. Tan YC, Sinclair H, Ghoorah K, Teoh X, Mehran R, Kunadian V. Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review. Eur Heart J Acute Cardiovasc Care. 2016 Nov;5(7):51-60. doi: 10.1177/2048872615610886;

4. Naji AA, Abbas AA, Hashem RB. Evaluation of serum RANKL level in acute coronary syndrome. Al-Kindy Coll Med J. 2014;10(2):45-8;

5. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002 May 7;105(18):2130-2. doi: 10.1161/01. cir.0000017140.26466.f5;

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3